doi: 10.3389/fcimb.2021.657775 278 TorzewskiJ.HeiglF.ZimmermannO.WagnerF.SchumannC.HettichR.et al
TAMs, particularly lipid-laden subsets, drive PCa invasiveness via IL-1-mediated upregulation of MARCO, which reciprocally triggers CCL6 secretion to enhance cancer cell migration (Masetti et al., 2022)
Dostawa nastpnego dnia Uwaga: Poniszy artyku ma charakter wycznie edukacyjny i informacyjny
Notably, the ALKIVIA study also demonstrated positive phase II/III results for VYVGART Hytrolu within idiopathic inflammatory myopathies, triggering its further development within this indication [253], for which efgartigimod is the FcRn antagonist with the most advanced clinical program as of January 2025
Synthesis: du Vigneaud, Miller, Biochem
The question most patients at Perfect B in Doral ask is not whether to stack, but which peptides to combine and how